Bio-Techne Corporation
TECH
$48.21
$0.841.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.25% | 3.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.25% | 3.25% | |||
| Cost of Revenue | -0.69% | 6.56% | |||
| Gross Profit | 8.41% | 1.58% | |||
| SG&A Expenses | -3.87% | -4.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.98% | -0.21% | |||
| Operating Income | 34.79% | 20.30% | |||
| Income Before Tax | 40.25% | 5.82% | |||
| Income Tax Expenses | 57.95% | 30.28% | |||
| Earnings from Continuing Operations | 34.30% | -0.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 34.30% | -0.46% | |||
| EBIT | 34.79% | 20.30% | |||
| EBITDA | 23.77% | 14.01% | |||
| EPS Basic | 33.87% | -0.69% | |||
| Normalized Basic EPS | 35.62% | 11.70% | |||
| EPS Diluted | 33.33% | 0.00% | |||
| Normalized Diluted EPS | 35.71% | 11.45% | |||
| Average Basic Shares Outstanding | 0.31% | 0.24% | |||
| Average Diluted Shares Outstanding | 0.26% | 0.41% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.25% | 0.01% | |||